Warning: mkdir(): Permission denied in /home/virtual/lib/view_data.php on line 81
Warning: fopen(upload/ip_log/ip_log_2024-04.txt): failed to open stream: No such file or directory in /home/virtual/lib/view_data.php on line 83
Warning: fwrite() expects parameter 1 to be resource, boolean given in /home/virtual/lib/view_data.php on line 84 A case of hyperinfection syndrome with Strongyloides stercoralis
A case of hyperinfection syndrome with Strongyloides stercoralis
Kyu Sik Choi,Young Nam Whang,Young Ja Kim,Yoon Mo Yang,Kyung Yoon,Jae Jin Kim,Duk Young Min and Keun Tae Lee
Hae Jeong Medical Hospital, Seoul, Korea.
Department of Parasitology, Yonsei University College of Medicine, Korea.
Abstract
A case of Strongyloides stercoralis infection wss experienced in a 73-year old Korean female patient, was hospitalized with relapse of cholecystitis. The patient developed cough and dyspnea 17 days after the admission. On the 27th hospitalized day, diarrhoea, nausea, vomiting and abdominal pain started. A number of parasitic larvae were incubated at 25 C for 2 days. Typical fork tailed filariform larvae of S. stercoralis (Bavay, 1876) Stiles and Hassall, 1902, were identified after cultivation. There was no improvement of diarrhoea after the medication with mebendazole. After the administration of thiabendazole, however, diarrhoea was stopped. On the 6th day of medication, S. stercoralis larvae were no more detected, and thereafter no larva was observed by repeated stool examinations upto 2 months after chemotherapy. The patient had the history of administration of steroid for articular rheumatism. Therefore this case seems to be a hyperinfection of S. stercoralis due to an autoinfection and to be the first report on the hyperinfected strongyloidiasis in Korea. Related literature was briefly reviewed.
Figures
Fig. 1 Blunt tail of Strongyloides stercoralis filariform larva (×600)
Tables
Table 1 Clinical feature of strongyloidiasis case during admission
Table 2 Measurement of Strongyloides stercoralis filariform larva in references
References
1.
Adam M, Morgan O, Persaud C, Gibbs WN. Hyperinfection syndrome with Strongyloides stercoralis in malignant lymphoma. Br Med J 1973;1(5848):264–266.
2.
Anast BP, et al. J Am Med Wom Ass 1963;18:623–632.
3.
Bezjak B. A clinical trial of thiabendazole in strongyloidiasis. Am J Trop Med Hyg 1968;17(5):733–736.
4.
Boyd WP Jr, Campbell FW, Trudeau WL. Strongyloides stercoarlis--hyperinfection. Am J Trop Med Hyg 1978;27(1 Pt 1):39–41.
5.
Burke JA. Strongyloidiasis in childhood. Am J Dis Child 1978;132(11):1130–1136.
6.
Cahill KM. Thiabendazole in massive strongyloidiasis. Am J Trop Med Hyg 1967;16(4):451–453.
7.
Cruz T, Reboucas G, Rocha H. Fatal strongyloidiasis in patients receiving corticosteroids. N Engl J Med 1966;275(20):1093–1096.
8.
Eveland LK, Kenney M, Yermakov V. Laboratory diagnosis of autoinfection in strongyloidiasis. Am J Clin Pathol 1975;63(3):421–425.
9.
Faust EC, et al. Am J Trop Med 1940;20:359–375.
10.
Grove DI. Strongyloidiasis in Allied ex-prisoners of war in south-east Asia. Br Med J 1980;280(6214):598–601.
11.
Grove DI. Strongyloides ratti and S. stercoralis: the effects of thiabendazole, mebendazole, and cambendazole in infected mice. Am J Trop Med Hyg 1982;31(3 Pt 1):469–476.
12.
Higenbottam TW, Heard BE. Opportunistic pulmonary strongyloidiasis complicating asthma treated with steroids. Thorax 1976;31(2):226–233.
13.
Jones CA. Clinical studies in human strongyloidiasis. I Semeiology. Gastroenterology 1950;16(4):743–756.
14.
Kenney M, Webber CA. Diagnosis of strongyloidiasis in Papanicolaou-stained sputum smears. Acta Cytol 1974;18(3):270–273.
15.
Lamb D, Pilney F, Kelly WD, Good RA. A comparative study of the incidence of anergy in patients with carcinoma, leukemia, hodgkin's disease and other lymphomas. J Immunol 1962;89:555–558.
16.
Little MD. Comparative morphology of six species of Strongyloides (Nematoda) and redefinition of the genus. J Parasitol 1966;52(1):69–84.
17.
Neefe LI, Pinilla O, Garagusi VF, Bauer H. Disseminated strongyloidiasis with cerebral involvement. A complication of corticosteroid therapy. Am J Med 1973;55(6):832–838.
18.
Purtilo DT, Meyers WM, Connor DH. Fatal strongyloidiasis in immunosuppressed patients. Am J Med 1974;56(4):488–493.
19.
Rassiga AL, Lowry JL, Forman WB. Diffuse pulmonary infection due to Strongyloides stercoralis. JAMA 1974;230(3):426–427.
20.
Rivera E, Maldonado N, Vélez-García E, Grillo AJ, Malaret G. Hyperinfection syndrome with Strongyloides stercoralis. Ann Intern Med 1970;72(2):199–204.
21.
Tanaka H, et al. Acta Med Univ Kagoshima 1965;7:185–198.
22.
Wang CC, Galli GA. Strongyloidiasis treated with pyrvinium pamoate. JAMA 1965;193:847–848.
23.
Lebedevakii BN. Soil-transmitted helminths. Report of a who expert committee on helminthiases. World Health Organ Tech Rep Ser 1964;277:1–70.
PDF Links
Full text via DOI
Download Citation 
